US pharmaceutical giant Pfizer on Tuesday announced a deal that it has signed with an UN-backed group to allow its promising Covid-19 treatment to be made and sold inexpensively in 95 poorer nations that are home to more than half of the world’s population. US pharmaceutical giant Pfizer on Tuesday announced a deal that it has signed with an UN-backed group to allow its promising Covid-19 treatment to be made and sold inexpensively in 95 poorer nations that are home to more than half of the world’s population.

 The company will make its oral antiviral medication available more cheaply in poorer countries if the promising pill passes trials and regulatory approval. The health officials said the fact that the deal was struck even before Pfizer's pill has been authorized anywhere, could help to end the pandemic quicker